| Revenue growth | Insurance revenue ₹4,686 Cr, +27.8% y-o-y (Ind AS). |
|---|---|
| Margins | CISR 99.5% vs 103.1%; claims ratio 63.1% vs 65.9%. |
| Demand visibility | Health segment industry GWP growth 20.7% vs 9.5% prior year. |
Growth
GWP +33.4% y-o-y (1/n); PAT ₹273.4 Cr vs ₹132.0 Cr (+107%); Q2 PAT ₹135.6 Cr; retail GWP +46.9%.
Outlook
No numeric guidance or capex plans given. Further AI projects planned for FY27 across value chain.
Risks
No explicit risks flagged; disclaimer cites regulation, competition, macro. Solvency ratio fell to 2.03x from 2.85x.
Last quarter's promises, checked
Delivered
- Retail growth 8-10pp above market → retail GWP +46.9% vs health industry +20.7% (≈+26pp, cross-basis) (= BEAT)
- Retail mix ~70% → 75.2% (= BEAT)
- No H2 loss-ratio deterioration → H1 claims ratio 63.1% vs 65.9% (= BEAT)
Partly delivered
- FY29 mid-to-high-teens ROE from 11.8% rolling → current ROE not disclosed (= PARTIAL)
Missed
- Debt decision on ₹250Cr NCD call option (due FY27) and ₹500Cr enabling resolution → no debt action disclosed (= MISS)
Investor Presentation filed with NSE, NSE: NIVABUPA. Summary written with AI assistance from the document.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹75.00
- Market cap
- ₹13,880 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 38.5×Sector 19.4×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance's Board approved the amendment and consolidation of its UPSI Fair Disclosure and Leak Inquiry policies. The integrated policy streamlines operational compliance under SEBI PIT Regulations.
Niva Bupa Health Insurance Company Q2 FY27 Results: Net Profit ₹135.6 Cr, Up 124.1% YoY
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,572 Cr (+25.5% YoY) and net profit of ₹135.6 Cr (+124.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹135.6 Cr · +124.1% YoY
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Niva Bupa Health Insurance Company Management Change
Niva Bupa Health Insurance Company Limited announced the sad demise of Mr. Roger William John Davis, a Non-Executive Non-Independent Director, effective October 17, 2026.